A. Barama et al., Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants, CLIN TRANSP, 14(3), 2000, pp. 212-217
Objective. To evaluate the influence of pre-transplant recipient sensitizat
ion on the outcome of 1-haploidentical live related donor (LRD) kidney tran
splants.
Method. We reviewed 141 consecutive cyclosporine-treated adult haploidentic
al first transplants for which panel reactive antibody (PRA) levels were av
ailable. Patients were divided into three groups according to their peak PR
A levels: group I, PRA = 0 (n = 97); group II, PRA = 1-50% (n = 24), and gr
oup III, PRA = 51-100% (n = 20).
Results. Differences in PRA were associated with significant differences in
short- and longer-term graft survival, unrelated to patient survival. Graf
t survival at 1. 3, and 5 yr was only 74, 40, and 27% in group III, compare
d to 92. 87, and 52% in group II, and 96, 91, and 85% in group I (p < 0.001
). Increasing PRA was associated with shorter time-to-graft failure. In gro
up III, 20% lost their transplant from acute rejection in the first 6 month
s, versus 4% in group II and 3% in group I (p < 0.01). Graft survival in gr
oup II diverged from that of group I only after 3 yr, due to an increase in
loss from chronic rejection. Hospitalization was longer in group III, in a
ssociation with a significantly higher incidence of acute rejection during
the first 3 months after transplantation (p < 0.02). Serum creatinine was h
igher in sensitized than nonsensitized patients at all time points.
Conclusions. Sensitization has a significant negative impact on the outcome
of haploidentical LRD kidney transplants. Sensitized potential recipients
and their potential donors should be aware of this in arriving at informed
decision-making for transplantation. These patients may benefit from more s
ensitive cross-match testing, more intense or more novel immunosuppression.
or immunomodulation to modify their immune responsiveness.